Defining synchronous oligometastatic non-small cell lung cancer: a systematic review.

[1]  P. V. Van Schil,et al.  Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  C. Dooms,et al.  MA25.03 Defining Oligometastatic Non-Small Cell Lung Cancer (NSCLC): An Evolving Multidisciplinary Expert Opinion , 2018, Journal of Thoracic Oncology.

[3]  N. Girard,et al.  MA25.02 Searching for a Definition of Synchronous Oligometastatic (sOMD)-NSCLC: A Consensus from Thoracic Oncology Experts , 2018, Journal of Thoracic Oncology.

[4]  N. Girard,et al.  MA25.01 EORTC Lung Cancer Group Survey to Define Synchronous Oligometastatic Disease in NSCLC , 2018, Journal of Thoracic Oncology.

[5]  B. V. Van Beers,et al.  Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group. , 2018, European journal of cancer.

[6]  S. Volpi,et al.  The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer. , 2018, Annals of translational medicine.

[7]  P. Iyengar,et al.  Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial , 2018, JAMA oncology.

[8]  F. Alongi,et al.  Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer. , 2017, Journal of thoracic disease.

[9]  Ming Chen,et al.  Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies , 2016, BMC Cancer.

[10]  J. Lee,et al.  Local Consolidative Therapy versus Maintenance Therapy/Observation for Patients with Oligometastatic Non-Small Cell Lung Cancer without Progression after Front-Line Systemic Therapy: Results of a Multi-Institutional Phase II Randomized Study , 2016, The Lancet. Oncology.

[11]  Henry Knipe,et al.  Oligometastases , 2016, Radiopaedia.org.

[12]  D. Boffa,et al.  Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer. , 2016, The Annals of thoracic surgery.

[13]  Y. Nishimura,et al.  Clinical outcome of node‐negative oligometastatic non–small cell lung cancer , 2016, Thoracic cancer.

[14]  C. Rübe,et al.  Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer , 2016, BMC Cancer.

[15]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  S Senan,et al.  Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  Ming Chen,et al.  Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China. , 2015, International journal of radiation oncology, biology, physics.

[18]  C. Simone,et al.  Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study. , 2015, Practical radiation oncology.

[19]  D. Gomez,et al.  Propensity score-matched analysis of comprehensive local therapy for oligometastatic non-small cell lung cancer that did not progress after front-line chemotherapy. , 2014, International journal of radiation oncology, biology, physics.

[20]  C. Nieder,et al.  Oligometastatic Non-Small Cell Lung Cancer: A Significant Entity outside of Specialized Cancer Centers? , 2014, Medical Principles and Practice.

[21]  Ravi B. Parikh,et al.  Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer. , 2014, International journal of radiation oncology, biology, physics.

[22]  B. Yaremko,et al.  Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors. , 2013, Lung cancer.

[23]  B. Passlick,et al.  Surgical Treatment of Extrapulmonary Oligometastatic Non-small Cell Lung Cancer , 2015, Indian Journal of Surgery.

[24]  R. Stahel,et al.  Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage. , 2012, Lung cancer.

[25]  P. Lambin,et al.  Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450) , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[26]  D. Gomez,et al.  Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis. , 2012, International journal of radiation oncology, biology, physics.

[27]  G. Apolone,et al.  Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience. , 2012, The Journal of thoracic and cardiovascular surgery.

[28]  P. Okunieff,et al.  Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer , 2011, Radiation oncology.

[29]  R. Onimaru,et al.  Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions. , 2010, Japanese journal of clinical oncology.

[30]  R. Abrams,et al.  Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC). , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  M. Kris,et al.  A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis. , 2002, Lung cancer.